Stopping primary prophylaxis in HIV-1-infected patients at high risk of toxoplasma encephalitis. Swiss HIV Cohort Study

Détails

Demande d'une copieDemande d'une copie
ID Serval
serval:BIB_5D6AF3410C19
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Lettre (letter): communication adressée à l'éditeur.
Collection
Publications
Institution
UNIL/CHUV
Titre
Stopping primary prophylaxis in HIV-1-infected patients at high risk of toxoplasma encephalitis. Swiss HIV Cohort Study
Périodique
Lancet
Auteur⸱e⸱s
Furrer  H., Opravil  M., Bernasconi  E., Telenti  A., Egger  M.
ISSN
0140-6736 (Print)
Statut éditorial
Publié
Date de publication
06/2000
Volume
355
Numéro
9222
Pages
2217-8
Notes
Letter
Multicenter Study
Research Support, Non-U.S. Gov't --- Old month value: Jun 24
Résumé
Discontinuation of primary prophylaxis against toxoplasma encephalitis was studied in 199 HIV-1-infected patients on antiretroviral combination treatment who had experienced a sustained increase in their CD4 count. During a follow-up of 272 person-years, no cases of toxoplasma encephalitis arose.
Mots-clé
AIDS-Related Opportunistic Infections/*prevention & control Adult Anti-HIV Agents/therapeutic use Anti-Infective Agents/therapeutic use CD4 Lymphocyte Count Chemoprevention Cohort Studies Confidence Intervals Encephalitis/*parasitology/prevention & control Female Follow-Up Studies *HIV Infections/drug therapy *Hiv-1 Humans Male Middle Aged Prospective Studies Switzerland Toxoplasmosis, Cerebral/*prevention & control
OAI-PMH
oai:serval.unil.ch:BIB_5D6AF3410C19
DOI
10.1016/S0140-6736(00)02407-7
Pubmed
10881897
Web of science
000087779000015
Création de la notice
25/01/2008 15:46
Dernière modification de la notice
20/08/2019 15:15
Données d'usage